comparemela.com

Latest Breaking News On - Regal investment advisors - Page 2 : comparemela.com

Enzi Wealth Decreases Stake in Tesla, Inc (NASDAQ:TSLA)

Enzi Wealth decreased its stake in shares of Tesla, Inc. (NASDAQ:TSLA – Free Report) by 13.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,504 shares of the electric vehicle producer’s stock after selling 240 shares during the period. Enzi Wealth’s holdings in Tesla were […]

Symmetry Investments LP Boosts Stock Holdings in Costco Wholesale Co (NASDAQ:COST)

Symmetry Investments LP raised its holdings in shares of Costco Wholesale Co. (NASDAQ:COST – Free Report) by 74.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,355 shares of the retailer’s stock after buying an additional 4,000 shares during the period. […]

Symmetry Investments LP Invests $1 57 Million in On Holding AG (NYSE:ONON)

Symmetry Investments LP purchased a new position in On Holding AG (NYSE:ONON – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 58,138 shares of the company’s stock, valued at approximately $1,568,000. A number of other hedge funds have also recently made changes to […]

CyberArk Software Ltd (NASDAQ:CYBR) Stock Holdings Trimmed by Wasatch Advisors LP

Wasatch Advisors LP trimmed its position in CyberArk Software Ltd. (NASDAQ:CYBR – Free Report) by 14.6% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,841,929 shares of the technology company’s stock after selling 315,252 shares during the period. CyberArk Software comprises 2.2% of Wasatch Advisors LP’s investment portfolio, making the stock its 6th […]

Avidity Partners Management LP Sells 91,100 Shares of Intra-Cellular Therapies, Inc (NASDAQ:ITCI)

Avidity Partners Management LP decreased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 11.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 710,000 shares of the biopharmaceutical company’s stock after selling 91,100 shares during the period. Intra-Cellular Therapies accounts for about […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.